Home / Ropivacaine / Czechia
CZ ATC N01BB09 · updated 2 Nov 2026
Ropivacaine shortage in Czechia
Is there a Ropivacaine shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Ropivacaine products are reported short in Czechia, the first since 1 Jul 2023. No return date has been given. Main reason: regulatory or licensing.
Also short in United States, Germany, Italy, Spain, Austria, Belgium, Sweden, New Zealand. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ROPIVACAINE BIOQ 2MG/ML 2MG/ML INF SOL APS 1X250ML | BioQ Pharma B.V., Amsterdam | 1 Jul 2023 | not given | Regulatory or licensing Procesní-registrační důvody |
| CZ | ROPIVACAINE BIOQ 2MG/ML 2MG/ML INF SOL APS 1X250ML+KATETR I | BioQ Pharma B.V., Amsterdam | 1 Jul 2023 | not given | Regulatory or licensing Procesní-registrační důvody |
| CZ | ROPIVACAINE BIOQ 2MG/ML 2MG/ML INF SOL APS 1X250ML+KATETR II | BioQ Pharma B.V., Amsterdam | 1 Jul 2023 | not given | Regulatory or licensing Procesní-registrační důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.